Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

84 results about "Cinacalcet Hydrochloride" patented technology

The orally bioavailable hydrochloride salt of the calcimimetic cinacalcet. Cinacalcet increases the sensitivity of calcium-sensing receptors on chief cells in the parathyroid gland to extracellular calcium, thereby reducing parathyroid hormone (PTH) secretion. A reduction in PTH levels inhibits osteoclast activity, which may result in a decrease in cortical bone turnover and bone fibrosis, and normalization of serum calcium and phosphorus levels. In addition, by reducing PTH levels, cinacalcet may reduce PSA levels; PTH appears to raise PSA levels and may increase prostate cancer cell growth.

Oral solid rapid release preparation of cinacalcet hydrochloride

The invention discloses an oral solid rapid release preparation of cinacalcet hydrochloride. The oral solid rapid release preparation comprises cinacalcet hydrochloride and medicinal auxiliary materials, wherein the average particle diameter of cinacalcet hydrochloride is 5-15 mum; the cinacalcet hydrochloride is needlelike crystalized fine particles; the medicinal auxiliary materials include a filling agent, a bonding agent, a disintegrating agent and a lubricating agent; and the preparation is in the form of a tablet. The oral solid rapid release preparation has the beneficial effects that: the average particle diameter of cinacalcet hydrochloride is defined, so that the dissolution rate and dissolution amount of cinacalcet are increased, a preparation process is simple and safe, the quality is controllable, and cost is low; and the oral solid rapid release preparation is suitable for industrial production.
Owner:CHINA RESOURCES SAIKE PHARMA

Amorphous cinacalcet hydrochloride and preparation thereof

Provided is amorphous cinacalcet hydrochloride, processes for the preparation thereof, and pharmaceutical compositions therewith.
Owner:TEVA PHARM USA INC

Cinacalcet hydrochloride solid dispersion tablet and preparation technology thereof

The invention discloses a preparation technology of a Cinacalcet hydrochloride solid dispersion tablet, and belongs to the technical field of preparation of medicinal preparations. The technology is characterized in that the Cinacalcet hydrochloride solid dispersion tablet is prepared through a solid dispersion process and a powder direct tabletting process. The in vitro dissolution rate of Cinacalcet hydrochloride is characterized by 40-80% at 5-10min, 80-90% at 15-20min and 90-100% at 30-45min. The technology has the advantages of simple process, safety, controllable quality, low cost, short production cycle, and suitableness for large-scale industrial production.
Owner:SHENYANG PHARMA UNIVERSITY

Method used for detecting cinacalcet hydrochloride isomerides via HPLC method

The invention relates to a method used for detecting cinacalcet hydrochloride isomerides via HPLC method, and belongs to the technical field of medicine. According to the method, HPLC method is adopted for detection of cinacalcet hydrochloride isomerides, and chromatographic conditions are defined as following: the adopted chromatographic column is Phenomenex Lux 5<mu> Cellulose-3 column (250mm*4.6mm, 5<mu>m), the adopted mobile phase is acetonitrile and a 0.01mol / L buffered saline solution, flow velocity is controlled to be 0.8 to 1.2ml / min, column temperature is controlled to be 25 to 35 DEG C, detection wave length is controlled to be 222nm, sample amount is controlled to be 10<mu>L. High performance liquid chromatography is adopted to detect two isomerides of cinacalcet hydrochloride in a synthesis finished product, accurate control on the quality of cinacalcet hydrochloride is realized, and it is beneficial for optimizing of technology, and increasing of product quality and safety.
Owner:HUAREN PHARMACEUTICAL CO LTD

Cinacalcet hydrochloride solid dispersion and preparation method thereof and cinacalcet hydrochloride oral solid dosage form

The invention discloses a cinacalcet hydrochloride solid dispersion and a preparation method thereof and a cinacalcet hydrochloride oral solid dosage form. The cinacalcet hydrochloride solid dispersion is prepared from cinacalcet hydrochloride and hydroxy propyl cellulose according to a hot-melt extrusion technology, wherein the weight ratio of cinacalcet hydrochloride to hydroxy propyl celluloseranges from 1:0.5 to 1:3. The preparation method comprises the following steps: uniformly mixing cinacalcet hydrochloride and hydroxy propyl cellulose based on the weight ratio; adding the mixture into a hot-melt extrusion machine for thermally melting and extruding; cooling and crushing the extruded materials to obtain the product. According to the preparation method, hydroxy propyl cellulose isused as a carrier; cinacalcet hydrochloride and hydroxy propyl cellulose are processed according to the hot-melt extrusion technology based on a certain weight ratio to prepare the solid dispersion; the solid dispersion is further processed into the solid form which is high in dissolution ratio in a neutral medium. The method is simple in process, convenient to operate, wide in raw material source, low in raw material price, and suitable for industrial mass production.
Owner:CHANGZHOU SUNLIGHT PHARMA

Method for preparing cinacalcet hydrochloride

The invention discloses a method for preparing cinacalcet hydrochloride and belongs to the field of synthesis and preparation of chemical drugs. The method disclosed by the invention comprises the following steps: taking bromo-alpha,alpha,alpha-trifluorotoluene (II) and acryloyl chloride (III) as raw materials, and preparing m-trifluoromethyl acrylketone (IV) through a coupled reaction; carrying out an addition reaction between (IV) and (R)-1-(1-naphthyl) ethamine (V) so as to generate (R)-3-(1-(1-naphthyl)ethylamino)-1-(3-trifluoromethyl)phenyl)-1-acetone (VI); reducing (VI) to prepare N-((1R)-1-(1-naphthyl)ethyl)-3-(3-trifluoromethyl)phenyl)-1-propylamine (cinacalcet) (VII); carrying out a salt forming reaction on cinacalcet, thereby obtaining N-((1R)-1-(1-naphthyl)ethyl)-3-(3-trifluoromethyl)phenyl)-1-propylamine hydrochloride, namely the cinacalcet hydrochloride (I). According to the route, the cheap and readily available bromo-alpha,alpha,alpha-trifluorotoluene (II) and acryloyl chloride (III) are taken as the raw materials, a few steps are needed, usage of compounds of a heavy metal Pd and metal reducing agents LiAlH4, NaBH4 and the like is avoided, and the method is safe, environmentally friendly and economic and is suitable for large-scale industrial production.
Owner:JIANGSU SUZHONG PHARM GRP CO LTD +1

Crystalline form of cinacalcet

InactiveUS20090197970A1Prevention of treatment of osteoporosisIncreased riskBiocideOrganic chemistryAcetic acidCinacalcet Hydrochloride
The present invention relates to the polymorph form II of Cinacalcet hydrochloride, methods for the preparation of pure form II of Cinacalcet hydrochloride, and pharmaceutical compositions comprising the new polymorphic form in an pharmaceutically effective amount The present invention also provides novel solvates of Cinacalcet hydrochloride, methods for the preparation of these solvates, the use of these novel solvates for the preparation of pure Cinacalcet hydrochloride, the use of these novel solvates for the preparation of polymorphic form II of Cinacalcet hydrochloride and pharmaceutical compositions comprising the acetic acid solvate of Cinacalcet hydrochloride.
Owner:SANDOZ AG

Method for synthesizing cinacalcet hydrochloride intermediate in microchannel reactor

The invention provides a method for synthesizing cinacalcet hydrochloride intermediate in a microchannel reactor. The method comprises the steps that 3-(3-trifluoromethylphenyl)-2-acrylic acid and a supported noble metal catalyst are added into an organic solvent A to react with hydrogen to generate 3-(3-trifluoromethylphenyl)propionic acid; after the reaction, filtration is conducted, and a catalyst B and thionyl chloride are added into filtrate to react to generate 3-(3-trifluoromethylphenyl)propionyl chloride, and the two intermediates are all finished in the microchannel reactor. By usingefficient mass transfer and heat transfer of the microchannel reactor, time of hydrogenation is effectively shortened, generation of esterification by-products in the hydrogenation process is prevented, the purity and yield of products are improved, palladium carbon is recovered and applied ,mechanically for many times, cumbersome operation in the kettle reaction process is overcome, and at the same time, materials generated in the reaction can be directly used for the next reaction; and the usage amount of the thionyl chloride in the preparation process of acyl chloride is reduced, waste discharge is reduced, and a green process for synthesizing cinacalcet hydrochloride intermediate is provided.
Owner:LIVZON GROUP CHANGZHOU KONY PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products